Bacillary angiomatosis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Bacillary angiomatosis Classification and external resources | |
| ICD-10 | A44.8 (ILDS A44.85), B20.1 (ILDS B20.11) |
|---|---|
| ICD-9 | 088.0 |
| DiseasesDB | 2173 |
| eMedicine | derm/44 |
| MeSH | D016917 |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Bacillary angiomatosis (BA) is a bacterial infection caused by either Bartonella henselae or Bartonella quintana. Bartonella henselae is most often transmitted through a cat scratch or bite, though ticks and fleas may also act as a vector. On the other hand, Bartonella quintana is usually transmitted by lice.
BA is characterised by the proliferation of blood vessels, resulting in them forming tumour-like masses in the skin and other organs. It most commonly manifests in people with AIDS, rarely appearing in those who are immunocompetent. While curable, it is potentially fatal if not treated.
Symptoms
Cutaneous BA is characterised by the presence of lesions on or under the skin. Appearing in numbers from one to hundreds, these lesions may take several forms:
- papules or nodules which are red, globular and non-blanching, with a vascular appearance
- purplish nodules sufficiently similar to Kaposi's sarcoma that a biopsy may be required to verify which of the two it is
- a purplish lichenoid plaque
- a subcutaneous nodule which may have ulceration, similar to a bacterial abscess
While cutaneous BA is the most common form of BA, BA can also affect several other parts of the body, such as the brain, bone, bone marrow, lymph nodes, gastrointestinal tract, respiratory tract, spleen and liver. Symptoms vary depending on which parts of the body are affected; for example, those whose livers are affected may have an enlarged liver and fever, while those with osseous BA will experience intense pain in the affected area.
Treatment and prevention
BA responds dramatically to several antibiotics. Usually, erythromycin will cause the skin lesions to gradually fade away in the next four weeks, resulting in complete recovery. Doxycycline may also be used. However, if the infection does not respond to either of these, the medication is usually changed to tetracycline. If the infection is serious, then a bactericidal medication may be coupled with the antibiotics.
If a cat is carrying Bartonella henselae, then it may not exhibit any symptoms. Cats may be bacteremic for weeks to years, but infection is more common in young cats. Transmission to humans is thought to occur via flea feces inoculated into a cat scratch or bite, and transmission between cats occurs only in the presence of fleas. Therefore, elimination and control of fleas in the cat's environment are key to prevention of infection in both cats and humans.
See also
External links
- HIV6 at FPnotebook
- Gasquet S, Maurin M, Brouqui P, Lepidi H, Raoult D (1998). "Bacillary angiomatosis in immunocompromised patients.". AIDS 12 (14): 1793-803. PMID 9792380.
WikiDoc Research Resources for Bacillary angiomatosis | |
|---|---|
| Articles on Bacillary angiomatosis | Most recent articles on Bacillary angiomatosis • Most cited articles on Bacillary angiomatosis • Review articles on Bacillary angiomatosis • Articles on Bacillary angiomatosis in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Bacillary angiomatosis | Powerpoint slides on Bacillary angiomatosis • Images of Bacillary angiomatosis • Photos of Bacillary angiomatosis • Podcasts & MP3s on Bacillary angiomatosis • Videos on Bacillary angiomatosis |
| Evidence Based Medicine Regarding Bacillary angiomatosis | Cochrane Collaboration on Bacillary angiomatosis • Bandolier on Bacillary angiomatosis • TRIP on Bacillary angiomatosis |
| Cost Effectiveness of Bacillary angiomatosis | Cost Effectiveness of Bacillary angiomatosis |
| Clinical Trials Involving Bacillary angiomatosis | Ongoing Trials on Bacillary angiomatosis at Clinical Trials.gov • Trial results on Bacillary angiomatosis • Clinical Trials on Bacillary angiomatosis at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Bacillary angiomatosis | US National Guidelines Clearinghouse on Bacillary angiomatosis • NICE Guidance on Bacillary angiomatosis • NHS PRODIGY Guidance • FDA on Bacillary angiomatosis • CDC on Bacillary angiomatosis |
| Textbook Information on Bacillary angiomatosis | Books and Textbook Information on Bacillary angiomatosis |
| Pharmacology Resources on Bacillary angiomatosis | Dosing of Bacillary angiomatosis • Drug interactions with Bacillary angiomatosis • Side effects of Bacillary angiomatosis • Allergic reactions to Bacillary angiomatosis • Overdose information on Bacillary angiomatosis • Carcinogenicity information on Bacillary angiomatosis • Bacillary angiomatosis in pregnancy • Pharmacokinetics of Bacillary angiomatosis • |
| Genetics, Pharmacogenomics, and Proteinomics of Bacillary angiomatosis | Genetics of Bacillary angiomatosis • Pharmacogenomics of Bacillary angiomatosis • Proteomics of Bacillary angiomatosis |
| Newstories on Bacillary angiomatosis | Bacillary angiomatosis in the news • Be alerted to news on Bacillary angiomatosis • News trends on Bacillary angiomatosis |
| Commentary on Bacillary angiomatosis | Blogs on Bacillary angiomatosis |
| Patient Resources on Bacillary angiomatosis | Patient resources on Bacillary angiomatosis • Discussion groups on Bacillary angiomatosis • Patient Handouts on Bacillary angiomatosis • Directions to Hospitals Treating Bacillary angiomatosis • Risk calculators and risk factors for Bacillary angiomatosis |
| Healthcare Provider Resources on Bacillary angiomatosis | Symptoms of Bacillary angiomatosis • Causes & Risk Factors for Bacillary angiomatosis • Diagnostic studies for Bacillary angiomatosis • Treatment of Bacillary angiomatosis |
| Continuing Medical Education (CME) Programs on Bacillary angiomatosis | CME Programs on Bacillary angiomatosis |
| International Resources on Bacillary angiomatosis | Bacillary angiomatosis en Espanol • Bacillary angiomatosis en Francais |
| Business Resources on Bacillary angiomatosis | Bacillary angiomatosis in the Marketplace • Patents on Bacillary angiomatosis |
| Informatics Resources on Bacillary angiomatosis | List of terms related to Bacillary angiomatosis |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
